MedTrace Logo

Evaluation of the Use of an E-health Therapeutic Education Application for Osteoarthritis Patients

NCT04750304 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 32

Last updated 2022-07-11

No results posted yet for this study

Summary

Osteoarthritis is the most common joint disease affecting the joint in a comprehensive and progressive manner. It leads to increasing disability.

The recommendations of recent years favor the non-pharmacological treatment of osteoarthritis including regular physical activity, therapeutic education and weight loss Osteoarthritis population has a low level of physical activity due to a lack of information, motivation and false beliefs related to physical activity and kinesiophobia (fear of movement) A preliminary qualitative study (ARTHe1) evaluating the barriers and levers of the use of an e-health therapeutic education application in patients with osteoarthritis was carried out in order to guide the development of the ARTHe application.

The objective of this study is to have the application tested on a panel of patients in order to assess the benefits of using the application in terms of adherence to the practice of physical activity but also in clinical terms on function and pain, and the satisfaction of the patient

Conditions

  • Osteo Arthritis Knee

Interventions

BEHAVIORAL

Application ARTHe

Patient will use ARTHe Application for 3 months

Sponsors & Collaborators

  • Openium

    collaborator UNKNOWN

  • Caleden

    collaborator UNKNOWN

  • Innovatherm

    collaborator INDUSTRY

  • BPIfrance

    collaborator OTHER

  • University Hospital, Clermont-Ferrand

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2022-07-07
Completion
2022-07-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04750304 on ClinicalTrials.gov